Lenvima 4 mg Capsules are an effective treatment option for various cancers, particularly thyroid cancer.
The active ingredient, Lenvatinib, is an oral receptor tyrosine kinase inhibitor. It targets specific proteins that aid tumor growth by supplying blood and nutrients. This action restricts the blood supply to tumors, slowing or stopping their development, making Lenvima Capsules an essential part of cancer treatment.
Eisai Pharmaceuticals India Pvt Ltd. manufactures Lenvima 4 mg Capsules, which are available in a 4mg dosage and require a prescription from a healthcare provider.
Lenvima 4 mg Capsules offer significant advantages in the treatment of various cancers. The active ingredient, Lenvatinib, blocks the blood supply to cancer cells, inhibiting their growth and spread.
Below are the key benefits:
Lenvima 4 mg can provide substantial improvements in managing these cancers, enhancing patients' quality of life.
Lenvima 4 mg Capsules are a prescription-based medication that should be taken as per a healthcare professional's instructions.
Here are general guidelines for taking this medication:
Always consult your healthcare professional for personalized advice on how to take this medication.
Lenvima 4 mg Capsules are available in various strengths and substitutes. Your doctor may adjust your dosage based on your specific condition and response to treatment.
Available Strengths and substitutes include:
| 1 capsules/s : $82.50 | |
| 1 Capsule/s : $11.06 |
Lenvima 4 mg Capsules are generally well-tolerated when taken as directed. Common side effects include:
These side effects are mild and temporary, often resolving as your body adjusts to the medication. Contact your doctor if they persist or worsen.
Liver disease
Lenvima Capsules should be used cautiously in patients with liver conditions. Dose adjustments may be necessary; consult your doctor for guidance.
Kidney impairment
Patients with kidney impairment should use Lenvima 4 Mg Capsules cautiously. Your healthcare provider may need to adjust the dosage based on your condition.
Pregnant and breastfeeding women
Lenvima 4 Mg Capsules may be unsafe during pregnancy and breastfeeding. It is essential to discuss the risks with your healthcare provider before use.
Avoid
Consult your doctor before consuming alcohol while taking Lenvima Capsules, as it may affect the medication's effectiveness. Avoid driving if you feel dizzy or experience side effects that impact your concentration.
If you take too many Lenvima 4 mg Capsules, it is essential to get medical help immediately. An overdose can cause severe health issues and intensify side effects. Don’t wait for symptoms to show—seek emergency assistance immediately.
If you miss a dose of Lenvima 4 mg Capsules, take it as soon as you remember. However, skip the missed dose if it is nearly time for your next scheduled dose. Do not take two doses at once to make up for the missed one, as this may increase the risk of side effects.
While taking Lenvima, it is advisable to avoid consuming alcohol and smoking, as they may interfere with the effectiveness of the medication. Also, consult your doctor before starting new medications or supplements to prevent potential interactions.
While taking Lenvima, it's essential to maintain good oral hygiene by brushing your teeth and cleaning your mouth thoroughly. Inform your doctor or dentist if you have a history of mouth, teeth, or jaw pain, mouth sores or swelling, numbness or heaviness in the jaw, or if you experience any loose teeth.
Lenvima Capsules work by targeting and inhibiting the growth of cancer cells. The active ingredient, Lenvatinib, restricts blood flow to tumors by limiting the supply of oxygen and nutrients, which helps prevent tumor growth and spread to other areas of the body.